Letter to the editor: COVID-19: how accurate are seroprevalence studies?
作者信息
Kadkhoda Kamran
机构信息
Immunopathology Laboratory, Robert J. Tomsich Pathology & Laboratory Medicine Institute, Cleveland Clinic, Cleveland, OH, United States.
出版信息
Euro Surveill. 2020 Jul;25(30). doi: 10.2807/1560-7917.ES.2020.25.30.2001374.
Abstract
摘要
相似文献
1
Letter to the editor: COVID-19: how accurate are seroprevalence studies?致编辑的信：2019冠状病毒病：血清流行率研究的准确性如何？
Euro Surveill. 2020 Jul;25(30). doi: 10.2807/1560-7917.ES.2020.25.30.2001374.
2
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020.2020 年 4 月 6 日，意大利伦巴第大区洛迪红区献血者中 SARS-CoV-2 特异性中和抗体的流行情况。
Euro Surveill. 2020 Jun;25(24). doi: 10.2807/1560-7917.ES.2020.25.24.2001031.
3
Letter to the Editor: The Interpretation of COVID-19 Seroprevalence Study Should Be Cautious.致编辑的信：对新冠病毒血清流行率研究的解读应谨慎。
J Korean Med Sci. 2020 Sep 28;35(38):e338. doi: 10.3346/jkms.2020.35.e338.
4
Authors' response: COVID-19: how accurate are seroprevalence studies?作者回应：2019冠状病毒病：血清流行率研究的准确性如何？
Euro Surveill. 2020 Jul;25(30). doi: 10.2807/1560-7917.ES.2020.25.30.2001437.
5
Lower prevalence of antibodies neutralizing SARS-CoV-2 in group O French blood donors.法国 O 型血献血者中，中和 SARS-CoV-2 的抗体流行率较低。
Antiviral Res. 2020 Sep;181:104880. doi: 10.1016/j.antiviral.2020.104880. Epub 2020 Jul 15.
6
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient blood.SARS-CoV-2 血清阳性率及中和活性在供者和患者血液中的变化。
Nat Commun. 2020 Sep 17;11(1):4698. doi: 10.1038/s41467-020-18468-8.
7
SARS-CoV-2 seroprevalence in COVID-19 hotspots.新冠疫情热点地区的新冠病毒血清流行率。
Lancet. 2020 Aug 22;396(10250):514-515. doi: 10.1016/S0140-6736(20)31482-3. Epub 2020 Jul 6.
8
SARS-CoV-2 seroprevalence in Spain.西班牙的新冠病毒血清流行率。
Lancet. 2020 Nov 7;396(10261):1484. doi: 10.1016/S0140-6736(20)32272-8.
9
SARS-CoV-2 seroprevalence in Spain.西班牙2019冠状病毒病血清流行率
Lancet. 2020 Nov 7;396(10261):1484. doi: 10.1016/S0140-6736(20)32273-X.
10
SARS-CoV-2 seroprevalence in Spain - Authors' reply.西班牙2019冠状病毒病血清流行率——作者回复
Lancet. 2020 Nov 7;396(10261):1484-1485. doi: 10.1016/S0140-6736(20)32266-2.
引用本文的文献
1
Association between ABO blood groups and SARS-CoV-2 infection in blood donors of Puglia region.ABO 血型与普利亚地区献血者中 SARS-CoV-2 感染的关系。
Ann Hematol. 2023 Oct;102(10):2923-2931. doi: 10.1007/s00277-023-05331-1. Epub 2023 Jul 13.
2
Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later.波黑萨拉热窝州针对 SARS-CoV-2 的抗体血清阳性率-一年后。
PLoS One. 2022 Mar 31;17(3):e0265431. doi: 10.1371/journal.pone.0265431. eCollection 2022.
3
SARS-CoV-2 IgG Seroprevalence among Blood Donors as a Monitor of the COVID-19 Epidemic, Brazil.巴西献血者中作为 COVID-19 流行监测指标的 SARS-CoV-2 IgG 血清阳性率。
Emerg Infect Dis. 2022 Apr;28(4):734-742. doi: 10.3201/eid2804.211961. Epub 2022 Feb 18.
4
SARS-CoV-2 Seroprevalence and Profiles Among Convalescents in Sichuan Province, China.中国四川省康复者中的 SARS-CoV-2 血清流行率和特征。
Front Public Health. 2021 Oct 26;9:716483. doi: 10.3389/fpubh.2021.716483. eCollection 2021.
5
SARS-CoV-2 population-based seroprevalence studies in Europe: a scoping review.基于人群的欧洲 SARS-CoV-2 血清流行率研究：范围综述。
BMJ Open. 2021 Apr 1;11(4):e045425. doi: 10.1136/bmjopen-2020-045425.
6
A novel comprehensive metric to assess effectiveness of COVID-19 testing: Inter-country comparison and association with geography, government, and policy response.一种评估 COVID-19 检测效果的新综合指标：国家间比较及其与地理位置、政府和政策应对的关联。
PLoS One. 2021 Mar 5;16(3):e0248176. doi: 10.1371/journal.pone.0248176. eCollection 2021.
7
Authors' response: COVID-19: how accurate are seroprevalence studies?作者回应：2019冠状病毒病：血清流行率研究的准确性如何？
Euro Surveill. 2020 Jul;25(30). doi: 10.2807/1560-7917.ES.2020.25.30.2001437.
本文引用的文献
1
Preexisting and de novo humoral immunity to SARS-CoV-2 in humans.人类对 SARS-CoV-2 的预先存在和新产生的体液免疫。
Science. 2020 Dec 11;370(6522):1339-1343. doi: 10.1126/science.abe1107. Epub 2020 Nov 6.
2
Prevalence of SARS-CoV-2 specific neutralising antibodies in blood donors from the Lodi Red Zone in Lombardy, Italy, as at 06 April 2020.2020 年 4 月 6 日，意大利伦巴第大区洛迪红区献血者中 SARS-CoV-2 特异性中和抗体的流行情况。
Euro Surveill. 2020 Jun;25(24). doi: 10.2807/1560-7917.ES.2020.25.24.2001031.
3
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.中国2019年冠状病毒病（COVID-19）疫情的特征及重要经验教训：来自中国疾病预防控制中心72314例病例报告的总结
JAMA. 2020 Apr 7;323(13):1239-1242. doi: 10.1001/jama.2020.2648.
4
Dengue and Zika Virus Diagnostic Testing for Patients with a Clinically Compatible Illness and Risk for Infection with Both Viruses.登革热和 Zika 病毒诊断检测用于具有临床相符疾病且同时感染两种病毒风险的患者。
MMWR Recomm Rep. 2019 Jun 14;68(1):1-10. doi: 10.15585/mmwr.rr6801a1.
Zotero 插件